Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
Open Access
- 21 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (21), 5104-5110
- https://doi.org/10.1182/blood-2008-11-191049
Abstract
Retroviral vectors containing internal promoters, chromatin insulators, and self-inactivating (SIN) long terminal repeats (LTRs) may have significantly reduced genotoxicity relative to the conventional retroviral vectors used in recent, otherwise successful clinical trials. Large-scale production of such vectors is problematic, however, as the introduction of SIN vectors into packaging cells cannot be accomplished with the traditional method of viral transduction. We have derived a set of packaging cell lines for HIV-based lentiviral vectors and developed a novel concatemeric array transfection technique for the introduction of SIN vector genomes devoid of enhancer and promoter sequences in the LTR. We used this method to derive a producer cell clone for a SIN lentiviral vector expressing green fluorescent protein, which when grown in a bioreactor generated more than 20 L of supernatant with titers above 107 transducing units (TU) per milliliter. Further refinement of our technique enabled the rapid generation of whole populations of stably transformed cells that produced similar titers. Finally, we describe the construction of an insulated, SIN lentiviral vector encoding the human interleukin 2 receptor common γ chain (IL2RG) gene and the efficient derivation of cloned producer cells that generate supernatants with titers greater than 5 × 107 TU/mL and that are suitable for use in a clinical trial for X-linked severe combined immunodeficiency (SCID-X1).This publication has 32 references indexed in Scilit:
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJCI Insight, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1JCI Insight, 2008
- An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activationBlood, 2008
- Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic CellsCell Stem Cell, 2008
- Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cellsBlood, 2007
- Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityBlood, 2006
- A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectorsMolecular Therapy, 2006
- Continuous high-titer HIV-1 vector productionNature Biotechnology, 2003
- Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral VectorsMolecular Therapy, 2001
- A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral VectorsMolecular Therapy, 2000